Xvivo Perfusion AB (XVIPF)
29.39
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Xvivo Perfusion Profit Margin (Quarterly) : 15.06% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Getinge AB | 5.40% |
| Paxman AB | -0.14% |
| Enovis Corp. | -1.43% |
| Edwards Lifesciences Corp. | 23.09% |
| IDEXX Laboratories, Inc. | 24.41% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 3.59% |
| Return on Assets | 3.19% |
| Return on Invested Capital | 3.42% |
| Gross Profit Margin (Quarterly) | 63.69% |
| Operating Margin (Quarterly) | 13.02% |
| Return on Net Operating Assets | 3.98% |